Regeneron Pharmaceuticals, Inc...
NasdaqGS:REGN
$ 735.13
+ $46.26 (6.72%)
$ 735.13
+ $46.26 (6.72%)
End-of-day quote: 10/03/2022

REGN - Regeneron Pharmaceuticals Stock Prediction 2025 - 2030

20 years of reliable Regeneron Pharmaceuticals stock forecast. The Wall Street analysts predict Outperform for REGN. See at a glance whether NasdaqGS:REGN will rise in the future.

$675.80
Forecast 2022
$744.31
Forecast 2025
$629.82
Forecast 2030
Outperform
TopGraphs Quality Ranking
Forecast 2022
$675.80
Forecast 2025
$744.31
Forecast 2030
$629.82
TopGraphs Quality Ranking
Outperform

Regeneron Pharmaceuticals Stock Forecast 2022

$758.00

In the last five quarters, Regeneron Pharmaceuticals's Price Target has risen from $585.71 to $696.64 - a respectable 18.94% increase. Fourteen analysts predict that Regeneron Pharmaceuticals's share price will increase slightly in the coming year, reaching 758.00. This would represent an increase of 8.81%.

3.11%
3.11

Highest Price Target $970.00

Average Price Target $758.00

Lowest Price Target $575.00

Regeneron Pharmaceuticals Stock Predictions 2025

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Jan 2025.

In January 2025, analysts believe the stock price will be $745.74. An increase of 1.44% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Feb 2025.

In February 2025, analysts believe the stock price will be $745.61. An increase of 1.43% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Mar 2025.

In March 2025, analysts believe the stock price will be $745.48. An increase of 1.41% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Apr 2025.

In April 2025, analysts believe the stock price will be $745.35. An increase of 1.39% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in May 2025.

In May 2025, analysts believe the stock price will be $745.22. An increase of 1.37% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Jun 2025.

In June 2025, analysts believe the stock price will be $745.09. An increase of 1.35% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Jul 2025.

In July 2025, analysts believe the stock price will be $744.96. An increase of 1.34% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Aug 2025.

In August 2025, analysts believe the stock price will be $744.83. An increase of 1.32% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Sep 2025.

In September 2025, analysts believe the stock price will be $744.70. An increase of 1.3% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Oct 2025.

In October 2025, analysts believe the stock price will be $744.57. An increase of 1.28% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Nov 2025.

In November 2025, analysts believe the stock price will be $744.44. An increase of 1.27% compared to the previous month's estimate.

Stock Forecast for the Price of an Regeneron Pharmaceuticals Share in Dec 2025.

In December 2025, analysts believe the stock price will be $744.31. An increase of 1.25% compared to the previous month's estimate.

Regeneron Pharmaceuticals Stock Prediction 2030

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Jan 2030.

In Jan 2030 analysts predict a share price of $639.00. An increase of 13.08% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Feb 2030.

In Feb 2030 analysts predict a share price of $638.16. An increase of 13.19% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Mar 2030.

In Mar 2030 analysts predict a share price of $637.33. An increase of 13.3% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Apr 2030.

In Apr 2030 analysts predict a share price of $636.50. An increase of 13.42% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in May 2030.

In May 2030 analysts predict a share price of $635.66. An increase of 13.53% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Jun 2030.

In Jun 2030 analysts predict a share price of $634.83. An increase of 13.64% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Jul 2030.

In Jul 2030 analysts predict a share price of $633.99. An increase of 13.76% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Aug 2030.

In Aug 2030 analysts predict a share price of $633.16. An increase of 13.87% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Sep 2030.

In Sep 2030 analysts predict a share price of $632.33. An increase of 13.98% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Oct 2030.

In Oct 2030 analysts predict a share price of $631.49. An increase of 14.1% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Nov 2030.

In Nov 2030 analysts predict a share price of $630.66. An increase of 14.21% compared to today's share price.

Stock Prediction for the Price of One Regeneron Pharmaceuticals Share in Dec 2030.

In Dec 2030 analysts predict a share price of $629.82. An increase of 14.32% compared to today's share price.

Company Info

P/E Ratio
15.6
Beta
0.17
Price-to-book Ratio
3.82
Market Cap
78.59B
TEV
54.463 B
LT Debt/Cap
0.01%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
-5.16%
Forecast 2Y
-0.36%
Analyst Price Target
$696.64

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Regeneron Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
15.6
Beta
0.17
Price-to-book Ratio
3.82
Market Cap
78.59B
TEV
54.463 B
LT Debt/Cap
0.01%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
-5.16%
Forecast 2Y
-0.36%
Analyst Price Target
$696.64

Financials

Year Year 2020 2021
Rev. Revenue
8310.40 16071.70
GM % Gross Margin %
53.6 66.7
OI Operating Income
3294.90 8946.80
OM Operating Margin
39.65 55.67
NI Net Income
3513.20 8075.30
EPS % Earnings Per Share %
31.47 74.66
Div. Dividends
0.00 0.00
PR % Payout Ratio %
0 0
Sha. Shares
104 107
OCF Operating Cash Flow
2618 7081
CS Cap Spending
-615 -552
FCF Free Cash Flow
2004 6529
FCFS Free Cash Flow Per Share
18.62 61.77

Regeneron Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching Regeneron Pharmaceuticals, Inc.?

The following analysts have recently covered Regeneron Pharmaceuticals:

Argus Research Company
Baird
Barclays
BMO Capital Markets Equity Research
BofA Global Research
Canaccord Genuity
CFRA Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc
Cowen and Company
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
RBC Capital Markets
Truist Securities
Wells Fargo Securities, LLC
Wolfe Research, LLC.
SVB Securities LLC
Moody’s
Baptista Research
Cantor Fitzgerald & Co.
UBS Investment Bank
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Regeneron Pharmaceuticals, Inc.?

The following sell-side analysts have recently covered Regeneron Pharmaceuticals:

Hellweg, Jasper
Skorney, Brian Peter
Gould, Carter Lewis
Seigerman, Evan David
Meacham, Geoffrey Christopher
Newman, John Lawrence
Glickman, Stewart
Leone, Dane Vincent
Bansal, Mohit
Van Buren, Tyler Martin
Schimmer, Joshua Elliott
Richter, Salveen Jaswal
Suneja, Yatin
Paraskevopoulos, Michail
Harrison, Matthew Kelsey
Andersen, Karen
Singh, Hartaj
Raymond, Christopher Joseph
Karnauskas, Robyn Kay Shelton
Davis, Luke
Risinger, David Reed
Tewari, Akash
Levesque, Michael
Majumdar, Ishan
Brayer, Olivia Simone
Schott, Christopher Thomas
Anderson, Timothy Minton
Bristow, Colin Nigel
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy